Two medtec firms expand Galway businesses
14 December 2015 | 0
Two medtech companies has announced the expansion of their operations in Galway. Both moves are supported by the IDA.
Medtronic, a global leader in medical technology, services and solutions based in Dublin, is to open a facility in Galway to manufacture the IN.PACT Admiral drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD). PAD is a build-up of plaque in arteries throughout the body leading to reduced blood flow to the limbs, organs, and the brain. Patients with PAD are at higher risk for stroke and heart attack.
Approximately 100 professionals in quality and manufacturing engineering, supply chain and production management, will be stationed at the new facility.
Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries.
The company employs over 3,000 people in Galway and more than 4,000 overall in Ireland.
In a separate development, German company phenox GmbH is to create 65 jobs at a new medical device manufacturing facility in Ballybrit over the next five years.
Phenox Ireland Ltd. will manufacture interventional neurovascular medical devices for the treatment of aneurysms and stroke. The company’s products are used by endovascular specialists for the interventional treatment of ischemic and hemorrhagic stroke and include mechanical thrombectomy devices, flow diverters and bifurcation aneurysm implants as well as access and support devices.
The company is locating its new facility at the Kamrick Court Building in Ballybrit Business Park and will complete a customised fit-out in early 2016.
Founded in 2005, phenox is headquartered in Bochum, Germany where it employs 130 people. The company is focused on neurovascular devices, developing and manufacturing innovative, cutting-edge products for the interventional treatment of ischemic and hemorrhagic stroke.